Publicaciones en colaboración con investigadores/as de Charité (37)

2024

  1. Calcium-activated potassium channels as amplifiers of TRPV4-mediated pulmonary edema formation in male mice

    Anesthesiology

  2. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

2023

  1. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 754-762

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

    RMD Open, Vol. 9, Núm. 1

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts

    The American journal of clinical nutrition, Vol. 117, Núm. 1, pp. 33-45

  6. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  7. Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

    RMD Open, Vol. 9, Núm. 1

2022

  1. 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

    Annals of the rheumatic diseases, Vol. 81, Núm. 1, pp. 34-40

  2. Mechanical ventilation promotes lung tumour spread by modulation of cholesterol cell content

    The European respiratory journal, Vol. 60, Núm. 1

  3. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  4. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 698-706

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts

    Transplantation, pp. 561-568

2020

  1. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584

  2. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

    Neurological Research and Practice, Vol. 2, Núm. 1

  3. The Ansa Subthalamica: A Neglected Fiber Tract

    Movement Disorders, Vol. 35, Núm. 1, pp. 75-80

2019

  1. Lung Purinoceptor Activation Triggers Ventilator-Induced Brain Injury

    Critical care medicine, Vol. 47, Núm. 11, pp. e911-e918